Investigation of the 5q33.3 longevity locus and age-related phenotypes

A large meta-analysis recently found the 5q33.3locus to be associated with survival to ≥ 90 years and lower allcause mortality, thus suggesting it as a third human longevity locus alongside APOE and FOXO3A.The 5q33.3 locus has previously been associated with blood pressure regulation and cardiovascular diseases in middle-aged individuals.However, part of the influence on mortality appears to be independent of cardiovascular phenotypes, and the role of the 5q33.3locus in longevity and survival is therefore still partly unknown.We investigated the association between the longevity-associated variant rs2149954 on chromosome 5q33.3and age-related phenotypes in two cohorts of 1,588 and 1,271 long-lived individuals (mean ages 93.1 and 95.9 years, respectively) as well as in 700 middle-aged and 677 elderly individuals (mean ages 52.5 and 78.7 years).Altogether, nominally significant associations between the rs2149954 minor allele and a decreased risk of heart attack and heart failure as well as increased physical functioning were found in the long-lived individuals.In the middle-aged and elderly individuals, rs2149954 minor allele carriers had a lower risk of hypertension.Our results thereby confirm a role of the 5q33.3locus in cardiovascular health and, interestingly, they also suggest a role in physical functioning.